Inactive Instrument

Apollo Endosurgery, Inc.

Equities

APEN

US03767D1081

Medical Equipment, Supplies & Distribution

Apollo Endosurgery, Inc. Announces Departure of Bret Schwartzhoff from His Position as Vice President, U.S. Sales and Global Marketing, Effective as of May 31, 2021

May 03, 2021 at 06:46 am EDT

On May 3, 2021, Apollo Endosurgery, Inc. announced the departure of Bret Schwartzhoff from his position as Vice President, U.S. Sales and Global Marketing, effective as of May 31, 2021, or the Departure Date.

Latest news about Apollo Endosurgery, Inc.

Apollo Endosurgery, Inc.(NasdaqGM:APEN) dropped from S&P TMI Index	23-04-06	CI
Apollo Endosurgery, Inc.(NasdaqGM:APEN) dropped from S&P Global BMI Index	23-04-06	CI
Apollo Endosurgery, Inc.(NasdaqGM:APEN) dropped from NASDAQ Composite Index	23-04-04	CI
Boston Scientific Corporation completed the acquisition of Apollo Endosurgery, Inc. from a group of shareholders.	23-04-03	CI
North American Morning Briefing : Stock Futures -2-	23-03-21	DJ
North American Morning Briefing : CPI Print Takes -2-	23-03-14	DJ
Cowen Downgrades Apollo Endosurgery to Market Perform From Outperform, Adjusts Price Target to $10 From $13	23-01-23	MT
North American Morning Briefing : Futures Dip As a -2-	23-01-05	DJ
Stifel Downgrades Apollo Endosurgery to Hold From Buy, Price Target is $10	23-01-04	MT
North American Morning Briefing : Stock Futures -2-	22-12-01	DJ
Lake Street Downgrades Apollo Endosurgery to Hold From Buy, Adjusts Price Target to $10 From $14	22-11-30	MT
Sector Update: Health Care Stocks Unable to Complete Tuesday Recovery	22-11-29	MT
Sector Update: Health Care Stocks Still Underwater in Tuesday Trade	22-11-29	MT
Top Midday Gainers	22-11-29	MT
Apollo Endosurgery Shares Hit 52-Week High on Boston Scientific Deal	22-11-29	DJ
Boston Scientific Strikes $615 Million Deal to Buy Medical Tech Firm Apollo Endosurgery	22-11-29	MT
Sector Update: Health Care Stocks Mixed Pre-Bell Tuesday	22-11-29	MT
Sector Update: Health Care	22-11-29	MT
Easing Concerns Over China COVID-19 Protests Prompt Quiet Premarket Session for US Equities	22-11-29	MT
Top Premarket Gainers	22-11-29	MT
Boston Scientific to Acquire Apollo Endosurgery for $615 Million; Apollo Shares Jump	22-11-29	MT
Boston Scientific to buy Apollo Endosurgery for $417 million	22-11-29	RE
Boston Scientific to Buy Apollo Endosurgery	22-11-29	DJ
Boston Scientific to acquire Apollo Endosurgery in $615 mln deal	22-11-29	RE
Boston Scientific Corporation entered into a definitive merger agreement to acquire Apollo Endosurgery, Inc. from a group of shareholders for approximately $500 million.	22-11-28	CI

Chart Apollo Endosurgery, Inc.

Duration

Period

More charts

Company Profile

Apollo Endosurgery, Inc. is a medical technology company, which is focused on the development of medical devices to advance gastrointestinal therapeutic endoscopy. The Company develops and distributes devices that are used by surgeons and gastroenterologists for various procedures related to gastrointestinal conditions including closure of gastrointestinal defects, managing gastrointestinal complications and the treatment of obesity. The Company's products include the OverStitch Endoscopic Suturing System, which enables advanced endoscopic procedures from within the Gastrointestinal tract, or endolumenally, by allowing physicians to suture, especially full-thickness, and secure the approximation of tissue. The X-Tack Endoscopic HeliX Tacking System is a suture-based device designed specifically for closing and healing defects in the lower gastrointestinal tract. The Orbera Intragastric Balloon System is a non-surgical alternative for interventional weight loss.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Sector Medical Equipment

	1st Jan change	Capi.
SHOCKWAVE MEDICAL, INC.	+75.69%	12.57B
PENUMBRA, INC.	-24.89%	7.29B
MASIMO CORPORATION	+10.43%	6.81B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+20.88%	5.67B
GETINGE AB	-16.83%	4.91B
APT MEDICAL INC.	+19.43%	4.18B
ASAHI INTECC CO., LTD.	-21.23%	3.86B
INARI MEDICAL, INC.	-23.31%	2.92B
NOVOCURE LIMITED	+51.84%	2.57B

Medical Equipment